Just when the world was breathing a sigh of relief, COVID-19’s new and aggressive EG.5 variant is making headlines. The recent surge, particularly gripping the US and UK, has health experts and governments scrambling. With the variant now detected in 45 countries and its prevalence skyrocketing, the global fight against this pandemic is far from over.

Rising Concerns and Vigilance

Data from the US Centers for Disease Control and Prevention (CDC) reveals an unsettling trend: hospital admissions and positive test rates linked to COVID-19 are spiking. Replacing the once-dominant “Arcturus” variant, EG.5 now accounts for a significant chunk of infections. Moreover, the World Health Organization (WHO) has spotlighted this variant, categorizing it under “variant under monitoring”. Interestingly, the mutation is an evolved version of XBB.1.9.2. With its growing prevalence during the American summer, health experts are nervously anticipating the winter season.

UK’s Eris Dilemma

Across the pond, the UK is wrestling with its own COVID-19 demon – the EG.5.1 variant, colloquially named Eris. Originating from the rampant Omicron, Eris has emerged as a significant threat. The UK Health Security Agency (UKHSA) now reports that Eris cases comprise an alarming 14.6% of total infections.

Staying Prepared

The CDC remains committed to guiding the public during these trying times. They highlight that while COVID-19 can present in varying severities, older individuals are particularly vulnerable. Their advice? Seek medical intervention promptly upon diagnosis, stay hydrated, and resort to over-the-counter meds when necessary. However, in cases of severe symptoms like breathlessness or chest pain, immediate medical attention is paramount.

It’s crucial for everyone to remain vigilant, adhere to safety measures, and keep abreast of updates from health agencies. As the world pivots to confront these new challenges, the hope for a more permanent solution intensifies.

  Centers for Disease Control and Prevention, COVID-19, EG.5, Eris, Omicron, UK Health Security Agency, UKHSA, United Kingdom, USA, World Health Organization